Business

Canopy Growth Expands European Medical Cannabis Supply Into the UK

Financial Post · September 22, 2026 at 7:44 a.m.

SMITHS FALLS, Ontario -- Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that it will supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom (the “UK”), expanding the reach of its international cannabis business into another European market.

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Canopy Growth Expands European Medical Cannabis Supply Into the UK

More from Financial Post

Mainstreet Equity Corp. Announces Quarterly Dividend for Period Ending September 30, 2026

JPMorgan Announces Cash Distributions for the JPMorgan ETFs

Stillwater Critical Minerals Corp. Begins Trading on OTCQX Best Market

Errington Metals Corp. Begins Trading on the OTCQX Best Market

More in Business

Mainstreet Equity Corp. Announces Quarterly Dividend for Period Ending September 30, 2026

JPMorgan Announces Cash Distributions for the JPMorgan ETFs

Stillwater Critical Minerals Corp. Begins Trading on OTCQX Best Market

Errington Metals Corp. Begins Trading on the OTCQX Best Market

Barrick to Report Third Quarter 2026 Results on November 9

Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia